VIRTUAL | November 1-3, 2021

 

Identifying and Advancing Novel Pain Drugs Through Clinical Development and Commercialization

Vivozon to Present Practical Methodology in Identifying Antionociceptive Multi-Target Drugs at Upcoming 10th Annual Pain Therapeutics Summit

June 21, 2016

Vivozon to Present Practical Methodology in Identifying Antionociceptive Multi-Target Drugs at Upcoming 10th Annual Pain Therapeutics Summit

As the steady decline of newly developed single-targeted drugs is becoming a challenge in the field, researchers are preferring to use a practical methodology in identifying antionociceptive multi-target drugs. The design of this approach allows for drugs to reflect multifactorial diseases caused by intricate networks of various mechanisms.

A recent review on the revolutionary trend in pursuing multi-targeting drugs has been released by several researchers in the field of neuropathic pain. 

Doo Lee, Chief Executive Officer at Vivozon, Inc, is one of the primary researchers conducting this review. Dr. Lee will be presenting his research at Arrowhead’s 10th Annual Pain & Migraine Therapeutics Summit, held October 19-20, 2016 in Chicago, Il. For more information on the conference, visit: www.paintherapeuticsummit.com.

This paper reviews several multi-target drugs to introduce the progress in establishing a methodology for the identification of antinociceptive multi-target drugs. By using a system of ex vivo efficacy screening using long-term potentiation in rat spinal cord as a surrogate biomarker for neuropathic pain, this methodology has the potential to revolutionize therapies for neuropathic pain. This technique is also used to lure an unknown target combination that causes synergistic mechanisms. For more information on the review, visit http://bit.ly/29Us9qG

The 10th Annual Pain & Migraine Therapeutics Summit is the US’s premier pain conference covering the field of pain research and therapeutics. With various stakeholders in pharmaceutical, biotech, device and medical communities attending, this conference will provide multi-faceted perspectives on the latest pain research. For more information, please download a brochure at: www.paintherapeuticsummit.com/brochure.

For more information, please contact:

John Waslif: Managing Director

Arrowhead Publishers

866-945-0263 ext 700

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Rachel Donlon: Marketing Associate

Arrowhead Publishers

866-945-0263 ext 701

This email address is being protected from spambots. You need JavaScript enabled to view it.

Organized and Produced by

 

Join our Social Media Groups

  
Pain Drug Development Group
                  
@PainConference

Conference Twitter Feed

About Us

Arrowhead Publishers' conferences offer more than simply presentations; we offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward. 
READ MORE

Contact Us

For general information about the conference, please contact us at:
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 +866.945.0263
 +866.945.0263
  PO Box 96, Chanhassen, MN 55317 USA

PRIVACY POLICY